Format

Send to

Choose Destination
Nat Rev Drug Discov. 2011 Feb;10(2):79-80. doi: 10.1038/nrd3360.

An accelerated pathway for targeted cancer therapies.

Author information

1
Engelberg Center for Health Care Reform, Brookings Institution, Washington DC, USA.

Abstract

A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers.

PMID:
21283090
DOI:
10.1038/nrd3360
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center